Loading...
Printed on 7/20/2026
For informational purposes only. This is not medical advice.
DoloPlus-2 is an observational pain scale for older adults with cognitive impairment who cannot reliably self-report pain. It includes somatic, psychomotor, and psychosocial reaction domains, with each item scored 0-3 for a total score of 0-30.
Formula: DoloPlus-2 total = somatic (0-15) + psychomotor (0-6) + psychosocial (0-9), range 0-30.
Save your results with a free account
Keep a history of calculations, favorite tools, and access your dashboard anytime.
DoloPlus-2 evaluates pain-related behavioral responses across three domains: (1) Somatic reactions — 5 items assessing somatic complaints, protective body postures, pain-induced facial expression, sleep, and activities of daily washing and dressing (each 0-3, maximum 15 points); (2) Psychomotor reactions — 2 items assessing mobility and movement (each 0-3, maximum 6 points); and (3) Psychosocial reactions — 3 items assessing communication, social activities, and behavioral problems (each 0-3, maximum 9 points). Each item is rated from 0 (normal behavior) to 3 (the most severe pain-consistent behavioral change). The scale requires familiarity with the patient's normal behavioral patterns and should be scored by a care team member who regularly observes the patient.
Add the somatic subtotal (0-15), psychomotor subtotal (0-6), and psychosocial subtotal (0-9) for a total score of 0-30. A score of 5 or above is commonly used as the operational threshold indicating clinically significant pain behavior requiring management attention. However, scores of 2-4 in the presence of a known pain-causing condition may still warrant analgesic review, while higher scores in patients with known behavioral disorders should be interpreted with caution.
Use the DoloPlus-2 score alongside clinical context to guide pain management decisions. After any analgesic or comfort intervention, reassess DoloPlus-2 within 30-60 minutes for acute pain or at the next assessment interval for chronic pain monitoring. A reduction of 2 or more points after intervention suggests the intervention addressed a pain component. Stable high scores despite analgesic treatment may indicate inadequate dosing, an unidentified pain source, or a non-pain cause of disturbance requiring further evaluation. Document all scores with assessment context, time, care activity, and any interventions administered.
Long-term care nurses, geriatricians, nursing home physicians
DoloPlus-2 was designed specifically for use in long-term care settings where many residents have moderate-to-severe dementia and cannot self-report pain reliably. Used at regular intervals and during caregiving activities, it provides structured, documented evidence of pain-behavior burden that drives analgesic prescribing decisions, care plan reviews, and interdisciplinary team discussions. Its three-domain structure captures the full range of pain-related behavioral change, from somatic through psychosocial.
Palliative care nurses, hospice staff, geriatricians
In palliative care for people with dementia, pain is a primary comfort concern that is frequently underrecognized and undertreated. DoloPlus-2 provides a systematic, validated framework for quantifying pain behavior burden and monitoring response to palliative analgesic interventions. The psychosocial domain captures social withdrawal and behavioral deterioration that frequently signals undertreated pain affecting quality of life in end-of-life settings.
Perioperative nurses, wound care nurses, rehabilitation nurses
DoloPlus-2 can be used after procedures such as wound dressing changes, catheterization, or orthopedic surgery in cognitively impaired older adults. Documenting pre- and post-procedural scores provides evidence of procedural pain burden and informs whether analgesic premedication should be provided before future procedures.
Geriatric psychiatrists, dementia nurse consultants, behavioral care specialists
Undertreated pain is a major and frequently overlooked driver of behavioral disturbance in severe dementia. DoloPlus-2 provides a structured framework for investigating whether behavioral change has a pain component before escalating behavioral medications. High scores in psychosocial items combined with somatic and psychomotor changes point toward pain-related behavioral presentation requiring analgesic trial before antipsychotic escalation.
Clinical governance staff, facility managers, quality coordinators
DoloPlus-2 scores can be tracked at an institutional level to audit the quality of pain identification and management in cognitively impaired residents. Tracking the proportion of residents with scores above 5 who have documented analgesic review, and monitoring trend scores after interventions, provides quality metrics for pain management programs in long-term care facilities.
The somatic domain includes washing, dressing, and mobility items that are most informative when scored during or after personal care and mobilization. Resting-state assessment alone systematically underestimates pain in patients with movement-related pain. Always assess DoloPlus-2 during or immediately after a care activity where pain-related behaviors are most likely to be expressed.
The psychosocial domain (communication, social activities, behavioral problems) captures pain-related behavioral deterioration particularly relevant in advanced dementia. Social withdrawal, reduced communication, and new behavioral problems in a previously stable patient should prompt DoloPlus-2 assessment, as these changes frequently reflect undertreated pain.
Each DoloPlus-2 item is rated as a change from the patient's normal baseline behavior. Staff who know the patient well produce more accurate ratings. A score of 3 means substantial change from what is normal for that individual, not just a severe behavior in absolute terms.
The commonly used threshold of 5 was derived from consensus. A score of 3-4 in the context of a known pain-causing condition (arthritis flare, constipation, pressure injury) should still prompt clinical pain review. The threshold is a guide, not a diagnostic criterion.
DoloPlus-2 relies on subjective behavioral observation across multiple domains, creating inter-rater variability. Regular team training using case vignettes and discussion of item-level scoring criteria significantly improves consistency. Annual DoloPlus-2 training refreshers are recommended for all nursing staff in long-term care settings.
Administering DoloPlus-2 before analgesic administration and again 30-60 minutes post-dose provides objective evidence of treatment response. A reduction of 2 or more points supports pain as the primary driver and the intervention as effective. No change may indicate inadequate dosing, wrong analgesic route, or a non-pain cause.
PAINAD (5 items, range 0-10) is faster and more focused on acute pain behaviors. DoloPlus-2 (10 items, range 0-30) includes psychosocial and ADL domains that capture chronic pain-related behavioral deterioration more comprehensively. DoloPlus-2 is better suited for longitudinal pain monitoring in long-term care; PAINAD may be more practical in acute or rapid-assessment contexts.
DoloPlus-2 has broad international use in cognitive-impairment populations, with a score of 5 or above commonly used as a practical pain-signal threshold. Originally developed and validated in France, it has the broadest behavioral scope among dementia pain scales due to its psychosocial domain. A systematic review by Rostad et al. (2017) confirmed acceptable measurement properties in nursing home populations.
Higher DoloPlus-2 totals indicate greater observed pain-behavior burden and support pain-management optimization with reassessment.
Use in cognitively impaired older adults, especially in long-term care and dementia-care settings where verbal pain report is unreliable.
Behavioral signs can be confounded by delirium, psychiatric symptoms, and non-pain distress; serial interpretation and clinical judgment are required.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.
Assess observational pain behaviors in advanced dementia using the 5-item PAINAD scale (0-10).
OpenGeriatricsScreen pain in people with severe dementia using the 6-domain Abbey Pain Scale (0-18).
OpenEmergencyEstimate pain behavior in non-verbal or critically ill adults using CPOT domains (facial expression, body movement, muscle tension, and ventilator/vocalization).
OpenEmergencyClassify bedside agitation or sedation from +4 (combative) to -5 (unarousable) using the Richmond Agitation-Sedation Scale.
Open